Literature DB >> 2714418

A role for the macrophage in normal hemopoiesis: III. In vitro and in vivo erythropoietin gene expression in macrophages detected by in situ hybridization.

C Vogt1, S Pentz, I N Rich.   

Abstract

Macrophages derived from unstimulated and unseparated mouse bone marrow cells cultivated on hydrophobic foils can release hemopoietic regulator molecules into the surrounding medium. To prove that one of these regulators exists in macrophages in vitro, in situ hybridization using a 1.2-kb erythropoietin (Epo) gene probe was employed. The probe was biotinylated and the signal developed using a streptavidin-gold reagent. Observation was performed using reflection-contrast microscopy. The results indicate that from a 98% pure population of macrophages, 34% F4/80 (mouse, macrophage-specific antigenic determinant)-positive macrophages exhibited Epo gene expression. The technique was also applied to normal, steady-state mouse bone marrow in which approximately 10% of the cells are F4/80-positive and of which about 3% demonstrated simultaneous Epo gene expression. As positive control, kidneys from anemic mice were hybridized with the biotin-labeled Epo DNA. A second positive control utilized biotin-labeled actin DNA hybridized to cultured macrophages and normal bone marrow cells. The accumulating information, demonstrating that the unstimulated kidney does not express the Epo gene, indicates that Epo is produced in other areas of the body under normal, steady-state conditions. The present results show that 1) macrophages can express the Epo gene, 2) this function is carried out by a subpopulation of macrophages, and 3) bone marrow macrophages in vivo may be responsible for the Epo production-target cell mechanism evoked by short-range and/or cell-to-cell interactions under normal, steady-state conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714418

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

1.  Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum-free medium.

Authors:  H Kimata; A Yoshida; C Ishioka; S Masuda; R Sasaki; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.

Authors:  T Sato; T Maekawa; S Watanabe; K Tsuji; T Nakahata
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Effect of recombinant human erythropoietin on human IgE production in vitro.

Authors:  H Kimata; A Yoshida; C Ishioka; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 4.  The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis.

Authors:  G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.

Authors:  Geza Acs; Paul J Zhang; Cindy M McGrath; Peter Acs; John McBroom; Ahmed Mohyeldin; Suzhen Liu; Huasheng Lu; Ajay Verma
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM).

Authors:  J D Geratz; R R Tidwell; J H Schwab; S K Anderle; K B Pryzwansky
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

7.  Erythropoietin gene expression in haemopoietic cell lines.

Authors:  E Abood; S Eridani; B Sawyer; N Westwood; T C Pearson
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

8.  Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart.

Authors:  Kavita Garg; Harlokesh N Yadav; Manjeet Singh; P L Sharma
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

9.  Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines.

Authors:  Yutaka Fujisue; Takatoshi Nakagawa; Kiyoshi Takahara; Teruo Inamoto; Satoshi Kiyama; Haruhito Azuma; Michio Asahi
Journal:  Oncol Lett       Date:  2013-04-03       Impact factor: 2.967

Review 10.  Growth factors in ischemic stroke.

Authors:  S Lanfranconi; F Locatelli; S Corti; L Candelise; G P Comi; P L Baron; S Strazzer; N Bresolin; A Bersano
Journal:  J Cell Mol Med       Date:  2009-12-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.